V. Paparizos

Pseudomonas fingernail infection successfully treated with topical nadifloxacin in HIV-positive patients: report of two cases.

A. Katsambas, E. Rallis, A. Flemetakis, 2010, AIDS.

Ustekinumab for the treatment of HIV psoriasis

E. Rallis, K. Kyriakis, V. Paparizos, 2012, The Journal of dermatological treatment.

A Nationwide Study about the Dispersal Patterns of the Predominant HIV-1 Subtypes A1 and B in Greece: Inference of the Molecular Transmission Clusters

A. Hatzakis, E. Kostaki, D. Paraskevis, 2020, Viruses.

Transmission Dynamics of HIV-1 Drug Resistance among Treatment-Naïve Individuals in Greece: The Added Value of Molecular Epidemiology to Public Health

E. Maltezos, A. Hatzakis, E. Kostaki, 2017, Genes.

International Congress of Drug Therapy in HIV Infection 23-26 October 2016, Glasgow, UK

Raúl Tabarés Gutiérrez, Samit R. Joshi, H. Jessen, 2016, Journal of the International AIDS Society.

Syphilis and gonorrhoea among people with HIV during pandemic times: a report from Athens, Greece

A. Stratigos, E. Daskalakis, S. Kourkounti, 2021, Sexually Transmitted Infections.

Monkeypox virus infection: First reported case in Greece in a patient with a genital rash

D. Rigopoulos, A. Papa, K. Tryfinopoulou, 2022, Journal of the European Academy of Dermatology and Venereology : JEADV.

Prevalence of drug resistance among HIV-1 treatment-naive patients in Greece during 2003-2015: Transmitted drug resistance is due to onward transmissions.

E. Maltezos, G. Magiorkinis, A. Hatzakis, 2017, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

Dating the Origin and Estimating the Transmission Rates of the Major HIV-1 Clusters in Greece: Evidence about the Earliest Subtype A1 Epidemic in Europe

E. Maltezos, G. Magiorkinis, A. Hatzakis, 2022, Viruses.

Monkeypox virus and secondary syphilis co‐infection in a HIV‐positive man

E. Gagari, A. Stratigos, E. Nicolaidou, 2023, Journal of the European Academy of Dermatology and Venereology : JEADV.

Estimation of the determinants for HIV late presentation using the traditional definition and molecular clock‐inferred dates: Evidence that older age, heterosexual risk group and more recent diagnosis are prognostic factors

G. Magiorkinis, A. Hatzakis, P. Lagiou, 2022, HIV medicine.

Earlier treatment initiation is associated with a decreased number of HIV-1 subtype A1 transmissions in Greece

E. Maltezos, G. Magiorkinis, A. Hatzakis, 2020, Sexually Transmitted Infections.